Charles River Laboratories (CRL): Cooke & Bieler LP added to its stake +260K shares
Cooke & Bieler LP added to its stake in Charles River Laboratories, per its Q1 2026 13F.
- 868K
- Shares reported · +260K vs prior quarter
- 1.7%
- Disclosed portfolio weight
- $150M
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- May 4, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 25, 2026Federal contract · $936K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $936K obligated to date
- Feb 28, 2026Federal contract · $5.3M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $5.31M obligated to date
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.4%
What came next
- May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, Charles River Laboratories International, Inc. (the “Company”) held its 2026 annual meeting of shareholders (the “Annual Meeting”). As further discussed below, at the Annual Meeting, the shareholders of the Company approved the Company’s 2026 Long-Term Incentive Plan (the “2026 Incentive Plan”).”
- May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 7.0%
- May 6, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 4.9%
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- Jun 1, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
- Jun 1, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
- Jun 29, 2026Insider · Their largest sale since 2006Director sold ~$16.9M of CRL shares in the open market
- Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 5, 2026Insider · Their largest sale since 2022Officer sold ~$1.33M of CRL shares in the open market
- Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 8.8%
- Aug 6, 2026Insider · 2 peopleInsiders: 10 sales (~$2.8M)
- Aug 10, 2026InsiderDirector sold ~$7.9M of CRL shares in the open market
- Aug 11, 2026Insider · 2 peopleInsiders: 2 sales (~$2.9M)
- Aug 13, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 6.2%
- Aug 18, 2026Federal contract · $372K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $372K obligated to date
- Aug 18, 2026InsiderDirector sold ~$163K of CRL shares in the open market
- Aug 19, 2026InsiderOfficer sold ~$600K of CRL shares in the open market
- Aug 25, 2026InsiderDirector sold ~$10.1M of CRL shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Charles River Laboratories
For Charles River Laboratories, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.
How this filing works
Explore the data
Common questions
What does this filing report about Charles River Laboratories (CRL) stock?
Cooke & Bieler LP added to its stake in Charles River Laboratories, per its Q1 2026 13F. Now 868K shares, $150M reported value, 1.7% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2026. Filed: May 4, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Charles River Laboratories recently?
For Charles River Laboratories, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the CRL page.
Does this mean CRL stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Charles River Laboratories
- SEC Form 13F-HRNov 16, 2026
- SEC Schedule 13GNov 16, 2026
- SEC Form 4Oct 26, 2026
- SEC Form 4Oct 23, 2026
- SEC Form 144Oct 22, 2026
- SEC Form 144Oct 21, 2026
Everything OQRO holds on this company is on its CRL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
